Company
Avencell
Next generation immunotherapies for hard-to-treat cancers.
Also known as AvenCell Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Watertown, MA, United States
- Founded
- 2021
- Legal name
- AvenCell Therapeutics, Inc.
- avencell.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Based on our deep science and focus on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.
Funding snapshot
- Total raised
- $402MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Grant, $40M2025-06-30
Funding rounds
- Grant
- $40M2025-06-30, Company stated
- Series B
- $112M2024-10-22, Company stated
- Round, 2021
- $250M2021-06-22, Company stated
Loading relationship preview